168 filings
Page 7 of 9
UPLOAD
PKBO
Peak Bio, Inc.
15 Aug 22
Letter from SEC
12:00am
UPLOAD
PKBO
Peak Bio, Inc.
12 Aug 22
Letter from SEC
12:00am
CORRESP
PKBO
Peak Bio, Inc.
5 Aug 22
Correspondence with SEC
12:00am
PRER14A
PKBO
Peak Bio, Inc.
29 Jul 22
Preliminary revised proxy
5:05pm
UPLOAD
PKBO
Peak Bio, Inc.
14 Jul 22
Letter from SEC
12:00am
PREM14A
PKBO
Peak Bio, Inc.
17 Jun 22
Preliminary proxy related to merger
4:47pm
10-Q
2022 Q1
PKBO
Peak Bio, Inc.
Quarterly report
19 May 22
4:15pm
NT 10-Q
PKBO
Peak Bio, Inc.
17 May 22
Notice of late quarterly filing
5:03pm
SC 13G/A
PKBO
Peak Bio, Inc.
9 May 22
Ignyte Acquisition / Oliveira Steven Michael ownership change
4:29pm
8-K
PKBO
Peak Bio, Inc.
29 Apr 22
Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company
5:27pm
10-K
2021 FY
PKBO
Peak Bio, Inc.
Annual report
30 Mar 22
8:21pm
8-K
PKBO
Peak Bio, Inc.
25 Mar 22
Entry into a Material Definitive Agreement
4:15pm
SC 13G/A
Flynn James E
11 Feb 22
Ignyte Acquisition / Flynn James E ownership change
12:00am
SC 13G
PKBO
Peak Bio, Inc.
4 Feb 22
Ignyte Acquisition / Saba Capital Management ownership change
11:30am
SC 13G/A
K2 Principal Fund, L.P.
26 Jan 22
Ignyte Acquisition / K2 PRINCIPAL FUND ownership change
5:25pm
SC 13G/A
PKBO
Peak Bio, Inc.
5 Jan 22
Ignyte Acquisition / K2 PRINCIPAL FUND ownership change
4:31pm
8-K
PKBO
Peak Bio, Inc.
16 Nov 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8:00am
10-Q
2021 Q3
PKBO
Peak Bio, Inc.
Quarterly report
15 Nov 21
5:30pm
10-Q
2021 Q2
PKBO
Peak Bio, Inc.
Quarterly report
16 Aug 21
5:11pm
10-Q
2021 Q1
PKBO
Peak Bio, Inc.
26 Jul 21
Quarterly report
7:15am